Platform
Features
0 followers
Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.
Industries
Headquarters
Employees
Links
9 members
4 members
Kyverna Therapeutics
6 followers
BioAge
3 followers
Cellares
2 followers
Boundless Bio
1 follower
UNC Charlotte
School District of Philadelphia
4 followers
Vaxcyte
Tango Therapeutics
Septerna
Brightseed
Watchmaker Genomics
Explore companies